In Vitro Release Behavior of Toremifene Citrate from Sol-Gel Processed Sintered Silica Xerogels

Factors affecting the adsorption and desorption of toremifene citrate (TC) on sintered silica xerogels were investigated in vitro. TC was attached onto sol-gel processed sintered silica xerogel grains or disks by adsorption. The adsorption of TC on the surface of silica was pH dependent. The results...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug development and industrial pharmacy 1999-01, Vol.25 (8), p.955-959
Hauptverfasser: Ahola, Manja, Kortesuo, Pirjo, Kangasniemi, Ilkka, Kiesvaara, Juha, Yli-Urpo, Antti
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 959
container_issue 8
container_start_page 955
container_title Drug development and industrial pharmacy
container_volume 25
creator Ahola, Manja
Kortesuo, Pirjo
Kangasniemi, Ilkka
Kiesvaara, Juha
Yli-Urpo, Antti
description Factors affecting the adsorption and desorption of toremifene citrate (TC) on sintered silica xerogels were investigated in vitro. TC was attached onto sol-gel processed sintered silica xerogel grains or disks by adsorption. The adsorption of TC on the surface of silica was pH dependent. The results support the conclusion that large pore size results in highest drug adsorption. Adsorption of TC was most effective in xerogels sintered at 700°C and containing the largest pores and lowest specific surface area of the silica xerogels studied in the adsorption tests. The release of TC from the xerogel matrix was linear with respect to the square root of time. The release of TC from the grains was very rapid for the first 5 hr, followed by a slower release. All drug was released from the grains, and 60% to 80% was released from the disks in 24 hr. All drug-silica xerogel formulations showed sustained in vitro release profiles.
doi_str_mv 10.1081/DDC-100102257
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1081_DDC_100102257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69931560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-3b10bafde910ec7f595f0b429392fc1a0998ba3ab1effd3dad96f6906b95575c3</originalsourceid><addsrcrecordid>eNp10E1v1DAQBmALUdFl4cgV-YC4hdpxnKyPsP2gUiUQLYibNXHGrCsnLuNsq_57DLt8HXqyD8-8Hr-MvZDijRQreXR8vK6kEFLUte4esYXUtah019aP2UKoVlVGNPqQPc35uqjaaP2EHUrRqEY2YsHs-cS_hJkS_4QRISN_hxu4DYl48vwqEY7B44R8XRDMyD2lkV-mWJ1h5B8pOcwZB34Zphnp1yUGB_wrUvqGMT9jBx5ixuf7c8k-n55crd9XFx_OztdvLyrXSD1XqpeiBz-gkQJd57XRXvRNbZSpvZMgjFn1oKCX6P2gBhhM61sj2r58qNNOLdnrXe4Npe9bzLMdQ3YYI0yYttm2xiipW1FgtYOOUs6E3t5QGIHurRT2Z6O2NGr_NFr8y33wth9x-EfvKizg1R5AdhA9weRC_utMiSqPL9lqx8LkE41wlygOdob7mOj3jHpohe6_0Q1CnDcOCO112tJUen1g-R-FQaHu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69931560</pqid></control><display><type>article</type><title>In Vitro Release Behavior of Toremifene Citrate from Sol-Gel Processed Sintered Silica Xerogels</title><source>MEDLINE</source><source>Business Source Complete</source><source>Taylor &amp; Francis:Master (3349 titles)</source><source>Taylor &amp; Francis Medical Library - CRKN</source><creator>Ahola, Manja ; Kortesuo, Pirjo ; Kangasniemi, Ilkka ; Kiesvaara, Juha ; Yli-Urpo, Antti</creator><creatorcontrib>Ahola, Manja ; Kortesuo, Pirjo ; Kangasniemi, Ilkka ; Kiesvaara, Juha ; Yli-Urpo, Antti</creatorcontrib><description>Factors affecting the adsorption and desorption of toremifene citrate (TC) on sintered silica xerogels were investigated in vitro. TC was attached onto sol-gel processed sintered silica xerogel grains or disks by adsorption. The adsorption of TC on the surface of silica was pH dependent. The results support the conclusion that large pore size results in highest drug adsorption. Adsorption of TC was most effective in xerogels sintered at 700°C and containing the largest pores and lowest specific surface area of the silica xerogels studied in the adsorption tests. The release of TC from the xerogel matrix was linear with respect to the square root of time. The release of TC from the grains was very rapid for the first 5 hr, followed by a slower release. All drug was released from the grains, and 60% to 80% was released from the disks in 24 hr. All drug-silica xerogel formulations showed sustained in vitro release profiles.</description><identifier>ISSN: 0363-9045</identifier><identifier>EISSN: 1520-5762</identifier><identifier>DOI: 10.1081/DDC-100102257</identifier><identifier>PMID: 10434140</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Adsorption ; Antineoplastic Agents, Hormonal - administration &amp; dosage ; Biological and medical sciences ; Crystallization ; Drug Carriers ; Estrogen Antagonists - administration &amp; dosage ; Gels ; General pharmacology ; Medical sciences ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Porosity ; Silicon Dioxide ; Solubility ; Spectrophotometry, Infrared ; Surface Properties ; Toremifene - administration &amp; dosage</subject><ispartof>Drug development and industrial pharmacy, 1999-01, Vol.25 (8), p.955-959</ispartof><rights>1999 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1999</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-3b10bafde910ec7f595f0b429392fc1a0998ba3ab1effd3dad96f6906b95575c3</citedby><cites>FETCH-LOGICAL-c415t-3b10bafde910ec7f595f0b429392fc1a0998ba3ab1effd3dad96f6906b95575c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1081/DDC-100102257$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1081/DDC-100102257$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,59623,59729,60412,60518,61197,61232,61378,61413</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1900199$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10434140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahola, Manja</creatorcontrib><creatorcontrib>Kortesuo, Pirjo</creatorcontrib><creatorcontrib>Kangasniemi, Ilkka</creatorcontrib><creatorcontrib>Kiesvaara, Juha</creatorcontrib><creatorcontrib>Yli-Urpo, Antti</creatorcontrib><title>In Vitro Release Behavior of Toremifene Citrate from Sol-Gel Processed Sintered Silica Xerogels</title><title>Drug development and industrial pharmacy</title><addtitle>Drug Dev Ind Pharm</addtitle><description>Factors affecting the adsorption and desorption of toremifene citrate (TC) on sintered silica xerogels were investigated in vitro. TC was attached onto sol-gel processed sintered silica xerogel grains or disks by adsorption. The adsorption of TC on the surface of silica was pH dependent. The results support the conclusion that large pore size results in highest drug adsorption. Adsorption of TC was most effective in xerogels sintered at 700°C and containing the largest pores and lowest specific surface area of the silica xerogels studied in the adsorption tests. The release of TC from the xerogel matrix was linear with respect to the square root of time. The release of TC from the grains was very rapid for the first 5 hr, followed by a slower release. All drug was released from the grains, and 60% to 80% was released from the disks in 24 hr. All drug-silica xerogel formulations showed sustained in vitro release profiles.</description><subject>Adsorption</subject><subject>Antineoplastic Agents, Hormonal - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Crystallization</subject><subject>Drug Carriers</subject><subject>Estrogen Antagonists - administration &amp; dosage</subject><subject>Gels</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Porosity</subject><subject>Silicon Dioxide</subject><subject>Solubility</subject><subject>Spectrophotometry, Infrared</subject><subject>Surface Properties</subject><subject>Toremifene - administration &amp; dosage</subject><issn>0363-9045</issn><issn>1520-5762</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E1v1DAQBmALUdFl4cgV-YC4hdpxnKyPsP2gUiUQLYibNXHGrCsnLuNsq_57DLt8HXqyD8-8Hr-MvZDijRQreXR8vK6kEFLUte4esYXUtah019aP2UKoVlVGNPqQPc35uqjaaP2EHUrRqEY2YsHs-cS_hJkS_4QRISN_hxu4DYl48vwqEY7B44R8XRDMyD2lkV-mWJ1h5B8pOcwZB34Zphnp1yUGB_wrUvqGMT9jBx5ixuf7c8k-n55crd9XFx_OztdvLyrXSD1XqpeiBz-gkQJd57XRXvRNbZSpvZMgjFn1oKCX6P2gBhhM61sj2r58qNNOLdnrXe4Npe9bzLMdQ3YYI0yYttm2xiipW1FgtYOOUs6E3t5QGIHurRT2Z6O2NGr_NFr8y33wth9x-EfvKizg1R5AdhA9weRC_utMiSqPL9lqx8LkE41wlygOdob7mOj3jHpohe6_0Q1CnDcOCO112tJUen1g-R-FQaHu</recordid><startdate>19990101</startdate><enddate>19990101</enddate><creator>Ahola, Manja</creator><creator>Kortesuo, Pirjo</creator><creator>Kangasniemi, Ilkka</creator><creator>Kiesvaara, Juha</creator><creator>Yli-Urpo, Antti</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990101</creationdate><title>In Vitro Release Behavior of Toremifene Citrate from Sol-Gel Processed Sintered Silica Xerogels</title><author>Ahola, Manja ; Kortesuo, Pirjo ; Kangasniemi, Ilkka ; Kiesvaara, Juha ; Yli-Urpo, Antti</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-3b10bafde910ec7f595f0b429392fc1a0998ba3ab1effd3dad96f6906b95575c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adsorption</topic><topic>Antineoplastic Agents, Hormonal - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Crystallization</topic><topic>Drug Carriers</topic><topic>Estrogen Antagonists - administration &amp; dosage</topic><topic>Gels</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Porosity</topic><topic>Silicon Dioxide</topic><topic>Solubility</topic><topic>Spectrophotometry, Infrared</topic><topic>Surface Properties</topic><topic>Toremifene - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahola, Manja</creatorcontrib><creatorcontrib>Kortesuo, Pirjo</creatorcontrib><creatorcontrib>Kangasniemi, Ilkka</creatorcontrib><creatorcontrib>Kiesvaara, Juha</creatorcontrib><creatorcontrib>Yli-Urpo, Antti</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug development and industrial pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahola, Manja</au><au>Kortesuo, Pirjo</au><au>Kangasniemi, Ilkka</au><au>Kiesvaara, Juha</au><au>Yli-Urpo, Antti</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vitro Release Behavior of Toremifene Citrate from Sol-Gel Processed Sintered Silica Xerogels</atitle><jtitle>Drug development and industrial pharmacy</jtitle><addtitle>Drug Dev Ind Pharm</addtitle><date>1999-01-01</date><risdate>1999</risdate><volume>25</volume><issue>8</issue><spage>955</spage><epage>959</epage><pages>955-959</pages><issn>0363-9045</issn><eissn>1520-5762</eissn><abstract>Factors affecting the adsorption and desorption of toremifene citrate (TC) on sintered silica xerogels were investigated in vitro. TC was attached onto sol-gel processed sintered silica xerogel grains or disks by adsorption. The adsorption of TC on the surface of silica was pH dependent. The results support the conclusion that large pore size results in highest drug adsorption. Adsorption of TC was most effective in xerogels sintered at 700°C and containing the largest pores and lowest specific surface area of the silica xerogels studied in the adsorption tests. The release of TC from the xerogel matrix was linear with respect to the square root of time. The release of TC from the grains was very rapid for the first 5 hr, followed by a slower release. All drug was released from the grains, and 60% to 80% was released from the disks in 24 hr. All drug-silica xerogel formulations showed sustained in vitro release profiles.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><pmid>10434140</pmid><doi>10.1081/DDC-100102257</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9045
ispartof Drug development and industrial pharmacy, 1999-01, Vol.25 (8), p.955-959
issn 0363-9045
1520-5762
language eng
recordid cdi_crossref_primary_10_1081_DDC_100102257
source MEDLINE; Business Source Complete; Taylor & Francis:Master (3349 titles); Taylor & Francis Medical Library - CRKN
subjects Adsorption
Antineoplastic Agents, Hormonal - administration & dosage
Biological and medical sciences
Crystallization
Drug Carriers
Estrogen Antagonists - administration & dosage
Gels
General pharmacology
Medical sciences
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Porosity
Silicon Dioxide
Solubility
Spectrophotometry, Infrared
Surface Properties
Toremifene - administration & dosage
title In Vitro Release Behavior of Toremifene Citrate from Sol-Gel Processed Sintered Silica Xerogels
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T05%3A34%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vitro%20Release%20Behavior%20of%20Toremifene%20Citrate%20from%20Sol-Gel%20Processed%20Sintered%20Silica%20Xerogels&rft.jtitle=Drug%20development%20and%20industrial%20pharmacy&rft.au=Ahola,%20Manja&rft.date=1999-01-01&rft.volume=25&rft.issue=8&rft.spage=955&rft.epage=959&rft.pages=955-959&rft.issn=0363-9045&rft.eissn=1520-5762&rft_id=info:doi/10.1081/DDC-100102257&rft_dat=%3Cproquest_cross%3E69931560%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69931560&rft_id=info:pmid/10434140&rfr_iscdi=true